Morbidity risk in HFE associated hereditary hemochromatosis C282Y heterozygotes (Q34904432)

5 August 2017

1 reference

title

Morbidity risk in HFE associated hereditary hemochromatosis C282Y heterozygotes (English)

1 reference

5 August 2017

Jurgen Fuchs

1

1 reference

5 August 2017

M Podda

series ordinal

2

1 reference

5 August 2017

L Packer

series ordinal

3

1 reference

5 August 2017

R Kaufmann

series ordinal

4

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

5 August 2017

13

1 reference

inferred from page(s)

published in

Toxicology

1 reference

5 August 2017

180

1 reference

5 August 2017

2

1 reference

5 August 2017

169-181

1 reference

Prevalence of the C282Y mutation of the hemochromatosis gene in liver transplant recipients and donors

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Should we genetically test everyone for haemochromatosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

C282Y mutation in the HLA-H gene is not a risk factor for patients with myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

HFE genotype in patients with hemochromatosis and other liver diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Management of Hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Haemochromatosis gene mutations and risk of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

The health effects of vitamin C supplementation: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

1 reference

7 January 2021

Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Historical overview of hemochromatosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Co-inheritance of mutations in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Liver transplantation for hereditary hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Ascorbic acid status in idiopathic hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Clinical aspects of hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Clinical and biochemical abnormalities in people heterozygous for hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Etiopathogenesis of nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

A history of phlebotomy therapy for hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

High prevalence of the hemochromatosis-associated Cys282Tyr HFE gene mutation in a healthy Norwegian population in the city of Oslo, and its phenotypic expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Genetic hemochromatosis: detection, management, and population screening

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Prevalence of hereditary haemochromatosis in premature atherosclerotic vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

C282Y mutation in HFE (haemochromatosis) gene and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

High-dose vitamin C: a risk for persons with high iron stores?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Role of free radicals and catalytic metal ions in human disease: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Association studies between haemochromatosis gene mutations and the risk of cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Heterozygosity for the hemochromatosis gene in liver diseases--prevalence and effects on liver histology

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Cancer risk following primary hemochromatosis: a population-based cohort study in Denmark.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Genes that modify the hemochromatosis phenotype in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Prevalence of elevated serum transferrin saturation in adults in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Deliberations and evaluations of the approaches, endpoints and paradigms for iron dietary recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Haemochromatosis gene mutations in idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Screening for hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

No evidence of increased risk of colorectal cancer in individuals heterozygous for the Cys282Tyr haemochromatosis mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Familial porphyria cutanea tarda: characterization of seven novel uroporphyrinogen decarboxylase mutations and frequency of common hemochromatosis alleles

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Are hereditary hemochromatosis mutations involved in Alzheimer disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Role of hemochromatosis C282Y and H63D mutations in HFE gene in development of type 2 diabetes and diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Relation between HFE mutations and mild iron-overload expression

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Iron and colorectal cancer risk: human studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Risk of neoplastic and other diseases among people with heterozygosity for hereditary hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Long-term survival in patients with hereditary hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

A population-based study of the clinical expression of the hemochromatosis gene

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Screening of patients with iron overload to identify hemochromatosis and porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Hemochromatosis gene variants in patients with cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Carriage of HFE mutations and outcome of surgical resection for hepatocellular carcinoma in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Uncommon mutations and polymorphisms in the hemochromatosis gene

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

1 reference

7 January 2021

Diagnosis of hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Haemochromatosis in the new millennium.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: the Atherosclerosis Risk in Communities (ARIC) study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

The frequency of hemochromatosis-associated alleles is increased in British patients with sporadic porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Low penetrant hemochromatosis phenotype in eight families: no evidence of modifiers in the MHC region

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

The hemochromatosis gene affects the age of onset of sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Prevalence of HFE (hemochromatosis gene) mutations in unselected male patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Safety aspects of iron in food

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Epidemiologic evidence of an association between body iron stores and risk of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Hydroxyl radicals and the toxicity of oral iron

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Moderate elevation of body iron level and increased risk of cancer occurrence and death

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Hemochromatosis heterozygotes may constitute a radiation-sensitive subpopulation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

C282Y and H63D mutation of the hemochromatosis gene in German porphyria cutanea tarda patients

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Iron-induced carcinogenesis: the role of redox regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Increased Risk of Acute Myocardial Infarction in Carriers of the Hemochromatosis Gene Cys282Tyr Mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

A novel mutation of HFE explains the classical phenotype of genetic hemochromatosis in a C282Y heterozygote

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Hemochromatosis-associated mortality in the United States from 1979 to 1992: an analysis of Multiple-Cause Mortality Data

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

Antioxidant status and lipid peroxidation in hereditary haemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900389-X

7 January 2021

10.1016/S0300-483X(02)00389-X

Identifiers

DOI

1 reference

5 August 2017

1 reference